Lucintel Forecasts The Global Liquid Biopsy Product Market To Grow With A Cagr Of 12.4% From 2025 To 2031

By Author: Lucintel LLC
Total Articles: 7861
Comment this article

According to a market report by Lucintel, the future of the global liquid biopsy product market looks promising with opportunities in the hospital & clinic and third-party laboratory markets. The global liquid biopsy product market is expected to grow with a CAGR of 12.4% from 2025 to 2031. The major drivers for this market are the increasing demand for non-invasive cancer diagnostics, the rising adoption of precision oncology testing, and the growing investment in advanced molecular diagnostics.
A more than 150-page report to understand trends, opportunity and forecast in global liquid biopsy product market to 2031 by type (CTCs, ctDNA, and exosomes), sample (blood sample, urine sample, and others), application (hospitals & clinics, third-party laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, ctDNA is expected to witness higher growth over the forecast period.
Within the application category, third-party laboratory is expected to witness higher growth.
Download sample by clicking on liquid ...
... biopsy product market.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Roche, Illumina, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Novogen, BGI, Myriad Genetics are the major suppliers in the liquid biopsy product market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Animal Medicine Simulator Market
Aliphatic Molecular Building Block Market
Equine Diagnostic Service Market
Enteric-Coated Softgel Capsule Market
Dioxin Analyzer Market